What is the ethical value of awarding patent rights that implicate regions of the brain?
References
Bush, G. Presidential proclamation 6158 (17 July 1990). http://www.loc.gov/loc/brain/proclaim.html
Insel, T.R., Landis, S.C. & Collins, F.S. Science 340, 687–688 (2013).
Markram, H. Sci. Am. 306, 50–55 (2012).
Okano, H., Miyawaki, A. & Kasai, K. Phil. Trans. R. Soc. Lond. B 370, 20140310 (2015).
Lynch, Z. Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment, and Business. Fernandez, A. (ed.) (SharpBrains, 2015).
Tyler, W.J. et al. US Patent No. 9,042,201 (2016).
Carroll, P. & Casimir, D. PCR Patent Issues. in PCR Protocols. Bartlett, J.M.S. & Stirling, D. (eds.) (Humana Press, New York, 2003).
Fendrick, S.E. & Zuhn, D.L. Cold Spring Harb. Perspect. Med. 5 http://dx.doi.org/10.1101/cshperspect.a020958 (20 August 2015).
Sherkow, J.S. & Scott, C. Nat. Biotechnol. 32, 620 (2014).
Sherkow, J.S. Nat. Biotechnol. 33, 256–257 (2015).
569 U.S. 12–398 133. S.Ct. 2107.
Bubela, T. et al. Nat. Biotechnol. 31, 202–206 (2013).
Novelli, E. Res. Policy 44, 493–507 (2015).
Foster, A.M. et al. US Patent No. 9,327,069 (2006).
Wagner, T.A. et al. US Patent No. 9,050,463 (2015).
Krueger, R. & Weiss, D. US Patent No. 9,283,378 (2012).
Sidiropoulos, C., LeWitt, P.A., Odekerken, V.J., Schuurman, P.R. & de Bie, R.M. Neurology 87, 745–746 (2016).
Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419–424 (2007).
Whiteford, H.A. et al. in Disease Control Priorities, 3rd edn., Vol. 4: Mental, Neurological, and Substance Use Disorders (eds. Patel, V. et al.) 29–40 (World Bank Publications, 2016).
35 USC § 101.
Young, J.E. Landslide 2, 44 (2009).
Pogge, T. J. Human Dev. Capabil. 13, 537–559 (2012).
Gold, E.R. & Caulfield, T.A. Lancet 359, 2268–2270 (2002).
Foster, K.R., Vecchia, P. & Repacholi, M.H. Science 288, 979–981 (2000).
Collingridge, D. The Social Control of Technology (St. Martin's Press, New York, 1980).
Acknowledgements
J.I. is Canada Research Chair in Neuroethics. Z.H.K. was a Clinical Scholar for the Alberta Heritage Foundation for Medical Research. Support for this work was made possible by CIHR grant # EOG-120257 (J.I.) and Alberta Innovates Health Solutions (Z.H.K.). D.R.-E. is a second-year law student at Dalhousie University. S.A.-R. is an expert patent researcher based in Calgary, Alberta. We thank Tania Bubela (University of Alberta) and Hendrik F.M. Van der Loos (University of British Columbia) for their expert advice.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Roskams-Edris, D., Anderson-Redick, S., Kiss, Z. et al. Situating brain regions among patent rights and moral risks. Nat Biotechnol 35, 119–121 (2017). https://doi.org/10.1038/nbt.3782
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3782
- Springer Nature America, Inc.
This article is cited by
-
Brain Patents as a Legal or Societal Challenge?
IIC - International Review of Intellectual Property and Competition Law (2023)
-
Reply to: "Brain modulation and patent law"
Nature Biotechnology (2019)
-
Brain modulation and patent law
Nature Biotechnology (2019)
-
Opening the debate on deep brain stimulation for Alzheimer disease – a critical evaluation of rationale, shortcomings, and ethical justification
BMC Medical Ethics (2018)